Cynthia L.  Lucchese net worth and biography

Cynthia Lucchese Biography and Net Worth

Director of Cooper Companies

Ms. Lucchese served as Chief Strategy Officer for Penske Entertainment Corp (previously Hulman and Company), a subsidiary of Penske Corporation, from November 2020 until her retirement in February 2023, and she served as Chief Administrative Officer and Chief Financial Officer from November 2014 to November 2020. Previously, she was Senior Vice President and Chief Financial Officer of Hillenbrand (NYSE: HI) from 2008 to 2014. She also served from 2005 to 2007 as Senior Vice President and Chief Financial Officer of Thoratec (NASDAQ: THOR), a medical device company focused on treating advanced stage heart failure, and she held various senior financial positions with Guidant Corporation (NYSE: GDT), now a part of Boston Scientific, from 1994 to 2005.

Ms. Lucchese serves on the board of Inari Medical (NASDAQ: NARI), a company focused on treatment of venous thromboembolism and other venous diseases, and she serves on the nominating & corporate governance committee and as chair of the audit committee.

She also serves on the board of Relievant Medsystems, Inc., a private medical device company focused on treatment of spinal pain, and the board of Beaver-Visitec, Inc., a private company focused on ophthalmic surgical devices, and serves as chair of the audit committee, and on the Dean’s Council of the Indiana University Kelley School of Business.

Ms. Lucchese previously served on the board of Hanger, Inc. (NYSE: HNGR), a provider of products and services that assist patients with disabilities or injuries, until its acquisition in October 2022 by Patient Square Capital, where she served on the audit committee, and on the board of Intersect ENT (NASDAQ: XENT) from 2014 until its acquisition by Medtronic, Inc. in 2022, where she served on the nominating & corporate governance committee and as chair of the audit committee. She also served on the board of Brightpoint, Inc. (NASDAQ: CELL) from 2009 until its acquisition by Ingram Micro, Inc. in 2012, where she served as chair of the audit committee and a member of the nominating & corporate governance committee, and on the Investment Board of the Next Level Indiana Fund through September 2022.

Ms. Lucchese earned her undergraduate degree in accounting and MBA from the Indiana University Kelley School of Business.

What is Cynthia L. Lucchese's net worth?

The estimated net worth of Cynthia L. Lucchese is at least $774.11 thousand as of December 22nd, 2025. Ms. Lucchese owns 9,445 shares of Cooper Companies stock worth more than $774,112 as of January 2nd. This net worth evaluation does not reflect any other investments that Ms. Lucchese may own. Learn More about Cynthia L. Lucchese's net worth.

How do I contact Cynthia L. Lucchese?

The corporate mailing address for Ms. Lucchese and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Cynthia L. Lucchese's contact information.

Has Cynthia L. Lucchese been buying or selling shares of Cooper Companies?

Cynthia L. Lucchese has not been actively trading shares of Cooper Companies during the last ninety days. Most recently, on Monday, December 22nd, Cynthia L. Lucchese bought 1,784 shares of Cooper Companies stock. The stock was acquired at an average cost of $84.06 per share, with a total value of $149,963.04. Following the completion of the transaction, the director now directly owns 9,445 shares of the company's stock, valued at $793,946.70. Learn More on Cynthia L. Lucchese's trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Lawrence Kurzius (Director), Jody Lindell (Director), Cynthia Lucchese (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Maria Rivas (Director), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, Cooper Companies insiders bought shares 10 times. They purchased a total of 33,989 shares worth more than $2,520,761.04. The most recent insider tranaction occured on December, 22nd when Director Cynthia L Lucchese bought 1,784 shares worth more than $149,963.04. Insiders at Cooper Companies own 2.0% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 12/22/2025.

Cynthia L. Lucchese Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2025Buy1,784$84.06$149,963.049,445View SEC Filing Icon  
See Full Table

Cynthia L. Lucchese Buying and Selling Activity at Cooper Companies

This chart shows Cynthia L Lucchese's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $81.32
Low: $80.80
High: $82.44

50 Day Range

MA: $76.51
Low: $68.88
High: $83.84

2 Week Range

Now: $81.32
Low: $61.78
High: $100.24

Volume

465,915 shs

Average Volume

2,961,346 shs

Market Capitalization

$15.94 billion

P/E Ratio

43.26

Dividend Yield

N/A

Beta

1.03